Please login to the form below
Calliditas
This page shows the latest Calliditas news and features for those working in and with pharma, biotech and healthcare.
Calliditas bets on PBC drug in Genkyotex buyout
Calliditas will acquire 62.7% of company for an initial 20.3m. Calliditas is set to acquire a controlling interest in French biotech Genkyotex, gaining access to its lead primary biliary ... Calliditas will acquire 62.7% of Genkyotex in an initial
Latest news
-
Swedish biotech Calliditas signs China licensing deal for autoimmune candidate
for this large patient population,” said Renée Aguiar-Lucander, chief executive of Calliditas. ... Calliditas has one competitor in the field, Omeros, which is developing its OMS721 for IgA nephropathy.
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
and bringing products to market will play a key role as we progress development of Nefecon through phase 3 clinical trials”, said Renée Aguiar-Lucander, CEO of Calliditas Therapeutics. ... He said: “I am excited to take on this role at Calliditas.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Healthcare Account Director
-
Competitive
-
Medical Editor
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Nucleus Global announces a trio of promotions
- UPDATED: Gilead says remdesivir likely to be effective against new COVID-19 strains
- Pfizer introduces new logo in a ‘shift from commerce to science’
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
